147 related articles for article (PubMed ID: 36708371)
21. Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.
Wang WC; Lai YC
J Ovarian Res; 2014 Sep; 7():88. PubMed ID: 25297715
[TBL] [Abstract][Full Text] [Related]
22. Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation.
Benayoun BA; Anttonen M; L'Hôte D; Bailly-Bechet M; Andersson N; Heikinheimo M; Veitia RA
Oncogene; 2013 May; 32(22):2739-46. PubMed ID: 22797072
[TBL] [Abstract][Full Text] [Related]
23. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
[TBL] [Abstract][Full Text] [Related]
24. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
25. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
[TBL] [Abstract][Full Text] [Related]
26. Adult-type granulosa cell tumors and FOXL2 mutation.
Köbel M; Gilks CB; Huntsman DG
Cancer Res; 2009 Dec; 69(24):9160-2. PubMed ID: 19996294
[TBL] [Abstract][Full Text] [Related]
27. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
How JA; Jazaeri A; Westin SN; Sood AK; Ramondetta LM; Xu M; Abonofal A; Karp DD; Subbiah V; Stephen B; Rodon JA; Yang F; Naing A
Invest New Drugs; 2021 Jun; 39(3):829-835. PubMed ID: 33415580
[TBL] [Abstract][Full Text] [Related]
28. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression.
Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN
Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948
[TBL] [Abstract][Full Text] [Related]
29. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
[TBL] [Abstract][Full Text] [Related]
30. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
Rosario R; Araki H; Print CG; Shelling AN
PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
[TBL] [Abstract][Full Text] [Related]
31. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of Differential Phosphorylation Sites of the Nuclear FOXL2 Protein as Potential Novel Biomarkers for Adult-Type Granulosa Cell Tumors.
Suh DS; Oh HK; Kim JH; Park S; Shin E; Lee K; Kim YH; Bae J
J Proteome Res; 2015 Jun; 14(6):2446-56. PubMed ID: 25871347
[TBL] [Abstract][Full Text] [Related]
33. [Juvenile granulosa-cell tumor: clinical and molecular expression].
Kalfa N; Philibert P; Patte C; Thibaud E; Pienkowski C; Ecochard A; Boizet-Bonhoure B; Fellous M; Sultan C
Gynecol Obstet Fertil; 2009 Jan; 37(1):33-44. PubMed ID: 19119048
[TBL] [Abstract][Full Text] [Related]
34. FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors.
Gershon R; Aviel-Ronen S; Korach J; Daniel-Carmi V; Avivi C; Bar-Ilan D; Barshack I; Meirow D; Ben-Baruch G; Cohen Y
Gynecol Oncol; 2011 Sep; 122(3):580-4. PubMed ID: 21640373
[TBL] [Abstract][Full Text] [Related]
35. Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation status.
Singh N; Gilks CB; Huntsman DG; Smith JH; Coutts M; Ganesan R; McCluggage WG
Histopathology; 2014 Apr; 64(5):626-32. PubMed ID: 24138090
[TBL] [Abstract][Full Text] [Related]
36. Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro.
Gal M; Orly J; Barr I; Algur N; Boldes R; Diamant YZ
Fertil Steril; 1994 May; 61(5):823-32. PubMed ID: 8174717
[TBL] [Abstract][Full Text] [Related]
37. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
Kim MS; Hur SY; Yoo NJ; Lee SH
J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
[TBL] [Abstract][Full Text] [Related]
39. Granulosa cell tumor mutant FOXL2C134W suppresses GDF-9 and activin A-induced follistatin transcription in primary granulosa cells.
McTavish KJ; Nonis D; Hoang YD; Shimasaki S
Mol Cell Endocrinol; 2013 Jun; 372(1-2):57-64. PubMed ID: 23567549
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanism for repression of 17alpha-hydroxylase expression and androstenedione production in granulosa cells.
Patel SS; Beshay VE; Escobar JC; Suzuki T; Carr BR
J Clin Endocrinol Metab; 2009 Dec; 94(12):5163-8. PubMed ID: 19850690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
